Common Contracts
3 similar Underwriting Agreement contracts by Cytokinetics Inc, Genius Sports LTD, Immatics N.V.
Genius Sports Limited 20,000,000 Ordinary Shares Underwriting AgreementUnderwriting Agreement • September 18th, 2023 • Genius Sports LTD • Services-miscellaneous amusement & recreation
The shareholder named in Schedule II hereto (the “Selling Shareholder”) of Genius Sports Limited, a company incorporated under the laws of Guernsey (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 20,000,000 ordinary shares (the “Firm Shares”), par value $0.01 per share, of the Company (the “Stock”) and, at the election of the Underwriters, up to 3,000,000 additional shares of Stock (the “Optional Shares”). The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares”. If no other Underwriters are listed on Schedule I hereto, all references to the Underwriters shall refer only to Goldman Sachs & Co. LLC.
Immatics N.V. Ordinary Shares (Nominal value €0.01 per share) Underwriting AgreementUnderwriting Agreement • October 12th, 2022 • Immatics N.V. • Biological products, (no disgnostic substances)
Jefferies LLC Jefferies GmbH SVB Securities LLC As representatives (the “Representatives”) of the several Underwriters named in Schedule I hereto, c/o Jefferies LLC 520 Madison Avenue New York, NY 10022 c/o Jefferies GmbH Bockenheimer Landstr. 24 60323 Frankfurt am Main c/o SVB Securities LLC 1301 Avenue of the Americas, 12th Floor New York, NY 10019
Cytokinetics, Incorporated 10,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • July 21st, 2021 • Cytokinetics Inc • Pharmaceutical preparations • New York
Cytokinetics, Incorporated, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 10,000,000 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 1,500,000 additional shares (the “Optional Securities”) of common stock, par value $0.001 (“Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Securities”).
